Jeff Yass’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
Other funds holding SPRY
Jeff Yass's SPRY Position: Q3 2026 in Review
Jeff Yass reduced its ARS Pharmaceuticals (SPRY) stake by 78% in Q3 2026, selling an estimated $267K and leaving 12,666 shares worth $54.6K. The position accounts for ﹤0.01% of the portfolio, ranked #12856.
Jeff Yass first reported a position in SPRY in Q2 2022 and has held it in 15 quarters since. The position peaked at $4.48M in Q2 2025. 187 funds tracked by Wall St. Rank hold SPRY as of Q3 2026.
- Jeff Yass held 12,666 shares of ARS Pharmaceuticals worth $54.6K as of Q3 2026.
- Jeff Yass sold 45,747 ARS Pharmaceuticals shares in Q3 2026, an estimated $267K.
- ARS Pharmaceuticals made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #12856 holding.
- Jeff Yass first reported a position in ARS Pharmaceuticals in Q2 2022 and has held it in 15 quarters since.
- Jeff Yass's ARS Pharmaceuticals position peaked at $4.48M in Q2 2025.
- 187 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.